AACR Annual Meeting 2019

Highlights from the AACR Annual Meeting 2019 

Integrative Cancer Science • Global Impact • Individualized Patient Care

March 29-April 3, 2019
Atlanta, Georgia

Program Committee Chair
John D. Carpten, USC Keck School of Medicine, Los Angeles, California

From March 29-April 3, Atlanta was the place to learn about the latest cutting-edge cancer science from all over the world. The AACR Annual Meeting 2019 brought together more than 21,000 laboratory researchers, clinicians, patient advocates, and other oncology professionals. As the leading forum for cutting-edge basic, translational, and clinical discoveries, the AACR Annual Meeting sets the research agenda for the international cancer community.

Meeting Highlights

Meeting Summaries. Cancer Research Catalyst (the AACR blog) covered the meeting in depth, highlighting both the cutting-edge science presented at the meeting as well as the perspective of patient advocates who participated in the AACR Scientist-Survivor Program. In addition, meeting attendees received expert summaries of the scientific highlights during a Wrap-Up Plenary Session.

Cancer Research Catalyst  |  Webcast: Wrap-Up Plenary

Meeting Webcasts.
The audio and slides of more than 200 presentationsincluding all Plenary Session presentationsare available free to everyone. The complete meeting webcast, consisting of more than 950 presentations, is available free to paid registrants or for purchase to non-attendees.
Webcasts  |  Login/Purchase Information

Poster Sessions.jpgAbstracts and Posters. More than 5,600 abstracts were presented at the meeting in poster sessions or minisymposia. These abstracts are freely available in multiple formats.

Online  |  eBook  |  PDF (17 MB) 

Spotlight on Clinical Trials. A record 213 clinical trials were presented at the Annual Meeting, 38 of which were selected for oral presentation. The highest-impact trials were featured in four Clinical Trial Plenary Sessions.

Webcasts and Abstracts

Sharpless.jpgNCI Directors’ Remarks. Outgoing director Norman E. Sharpless, MD, FAACR, and incoming acting director Douglas R. Lowy, MD, FAACR, shared their thoughts on progress and collaboration in the field.

The meeting program also included several NCI/NIH-sponsored sessions.


Regulatory Science and Science Policy Sessions. These sessions highlighted recent regulatory developments and provided an open forum for the discussion of cutting-edge issues in cancer drug, biologic, and diagnostic regulation.
Webcasts  |  Session Summaries

Media Coverage/Social Media Impact. The meeting generated global interest as illustrated by the significant amount of news coverage and social media activity.

Article Collections. The AACR journal editors are proud to present collections of recently published, impactful articles related to the Annual Meeting 2019 sessions.

View Articles

Professional Development Opportunities. The AACR provided Annual Meeting attendees at all career stages—from high school students to senior investigators—with the resources to enhance and advance their careers.

Professional Development Opportunities 


Top of page